Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1089 | 982 | 1260 | 1062 | 1356 | 1638 |
Fund Return | 8.85% | -1.79% | 25.98% | 2.02% | 6.27% | 5.06% |
Place in category | 205 | 532 | 70 | 249 | 262 | 172 |
% in Category | 25 | 79 | 9 | 45 | 42 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pax Global Environmental Mrkts Inst | 2.21B | 8.72 | 0.73 | 8.67 | ||
Pax Balanced Individual Investor | 1.36B | 7.61 | 1.10 | 6.67 | ||
Pax Large Cap Fund Institutional | 1.31B | 12.73 | 3.92 | - | ||
Pax MSCI International ESG Idx Inst | 1.16B | 9.08 | 2.32 | 5.33 | ||
Pax Balanced Institutional | 958.94M | 7.82 | 1.34 | 6.94 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 204.36B | 8.15 | 1.40 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.61B | 8.18 | 1.45 | 4.94 | ||
Fidelity International Index Inst | 52.9B | 6.96 | 2.81 | 5.35 | ||
Fidelity Series Global ex US Index | 48.18B | 8.52 | 1.64 | 4.77 | ||
Strategic Advisers International I | 42.32B | 8.45 | 1.91 | 6.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 2.64 | 10,612.0 | +0.17% | |
Novartis | CH0012005267 | 2.59 | 93.27 | -0.12% | |
Novo Nordisk B | DK0062498333 | 2.55 | 757.3 | +1.30% | |
Schneider Electric | FR0000121972 | 2.22 | 243.50 | +1.73% | |
HSBC | GB0005405286 | 2.21 | 732.70 | +0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review